The Week Ahead: Walt Disney, CVS, and Berkshire Hathaway to Report Earnings
The week ahead in earnings winds down, but we have our eyes on these big names.
Earnings from the June quarter are starting to wind down, but in the week ahead we still expect to see reports from big names, starting with Walt Disney (DIS) on Tuesday, then CVS Health Corp (CVS) on Wednesday, and lastly Berkshire Hathaway (BRK.) (BRK.B) on Friday.
Although the lockdowns in March had consumers fleeing to at-home entertainment for comfort and distraction, the first quarter of 2020 saw significant television customer losses. With revenue streams from content licensing, we expect that the traditional television business and firms like Walt Disney will remain large enough. We believe these factors will support excess returns on capital over the next decade; however, we trimmed our fair value estimate for Disney after the media industry’s rough start in 2020. We had expectations that the industry would find creative ways to improve the price/value equation for consumers and fix its television problems, but our outlook has dimmed as streaming offerings become the priority.
Carole Hodorowicz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.